IMPORTANCE Headache can be a functional indication for ptosis repair and blepharoplasty.
T he levator aponeurosis and the underlying Müller muscle retract the eyelid to open the eye. In contrast, contraction of the occipitofrontalis muscle raises the eyebrow and can assist in lifting the eyelid through the orbicularis fascia. [1] [2] [3] In aponeurotic blepharoptosis, the levator aponeurosis and the underlying Müller muscle are disinserted from the tarsus and are attenuated and elongated. Matsuo et al 2, 3 reported that, because of slippage between the levator aponeurosis and the tarsus, stretching of the mechanoreceptors in the Müller muscle is increased even in primary gaze and induces phasic and tonic reflex contraction of the occipitofrontalis muscles. Dermatochalasis, or excess upper eyelid skin, may interfere with the superior visual field. Droopiness of the eyelids can lead to reflex contraction of the occipitofrontalis muscles as it does in patients with ptosis. As a result of tonic reflex contraction of the occipitofrontalis muscle, dermatochalasis may also induce tension-type headache. [3] [4] [5] Tension-type headache is the most common form of primary headache, with a mean lifetime prevalence of 46%. 6 The chronic form of a tension-type headache is a serious disease causing a marked decrease in quality of life and significant disability. However, its etiologic factors are uncertain, although activation of peripheral afferent neurons from the head and neck muscles may play a role. 6, 7 Injection of botulinum toxin and excision of the corrugator superciliaris muscle are the treatment options in the oculofacial literature for patients with tension-type headache. 4, [8] [9] [10] [11] [12] [13] [14] [15] This study prospectively examines patients who have undergone ptosis repair and blepharoplasty. Their changes in headache-related quality of life were evaluated by using a validated headache-related quality-of-life survey, the Headache Impact Test-6 (HIT), 16 to determine whether any change occurs in the HIT scores following these surgical procedures.
Methods
The patient population was prospectively selected from an ophthalmology clinic oculoplastic department. All patients who underwent standard upper eyelid blepharoplasty or ptosis repair (levator resection, Müller muscle resection, or frontalis suspension) by 1 oculoplastic surgeon (I.B.S.) from September 1, 2014, to September 1, 2015, were included. The patients who underwent blepharoplasty are group 1; those who underwent ptosis repair are group 2. All participants provided verbal informed consent. The study was conducted in compliance with the principles of the Declaration of Helsinki. 17 The
Biruni University Hospital Institutional Review Board approved this study.
Patients were asked if they had any headache before the operation. Those who did were asked if they had been diagnosed with tension-type, migraine, or any other type of headache by their neurologist or primary care physician according to the criteria of the International Headache Society. 6 The HIT 16 was administered preoperatively and postoperatively to patients who had tension-type headache. Patient information was collected from clinical visits, clinical medical records, and telephone interviews. The minimum time interval after the operation was 3 months (mean, 13.5 weeks; range, 12-17 weeks).
Patients were excluded if they had known orbital, corneal, or intracranial pathologic conditions; a history of trauma; had received botulinum toxin; a change in headache medications; or headache other than tension-type headache. Patients who did not agree to participate were excluded from the study.
Statistical analysis was performed with SPSS for Windows, version 22.0 (IBM Corp). Measurable data are presented as mean (SD). The range of the variable data was measured using a Kolmogorov-Smirnov test. Quantitative data were analyzed with independent samples using a 2-tailed t test and a Mann-Whitney test. Qualitative data were analyzed using a χ 2 test. Repetitive data were analyzed using a Wilcoxon test.
P < .05 was considered statistically significant.
Results
A total of 152 patients met the inclusion criteria. Thirty-eight patients (35.2%) in group 1 and 28 patients (63.6%) in group 2 had tension-type headache (P = .001). In both groups, the mean (SD) postoperative HIT scores were statistically significantly better than the preoperative HIT scores (group 1: preoperative score, 55.9 [6.6] , and postoperative score, 46.4 [9.0]; group 2: preoperative score, 60.0 [7.2] , and postoperative score, 42.3 [9.3] ; P = .001). In group 2, the mean (SD) preoperative HIT score was significantly higher than in group 1 (60.0 [7.2] vs 55.9 [6.6] ; P = .007) and the postoperative HIT score was significantly lower than in group 1 (42.3 [9.3] vs 46.4 [9.0]; P = .03). In addition, the mean (SD) difference between the preoperative and postoperative HIT score was significantly higher in group 2 (17.8 [9.9] ) than in group 1 (9.5 [8.6] ; P = .002) ( Table 2 and Figure 1 ).
Key Points
Question Can ptosis repair or blepharoplasty lead to an improvement in headache-related quality of life?
Findings In this cohort study, postoperative Headache Impact Test-6 scores were significantly better than preoperative scores in patients who underwent ptosis repair and those who underwent blepharoplasty. The Headache Impact Test-6 score decline ratio was significantly higher in patients who underwent ptosis repair than in those who underwent blepharoplasty.
Meaning Tension-type headache can be a functional indication for upper eyelid ptosis repair and blepharoplasty.
In group 2, there was no significant difference between patients undergoing the Müller muscle resection, frontalis suspension, or levator resection in the mean (SD) preoperative (59. Table 3 ). In addition, for group 2, there was a statistically significant negative correlation between the results on the marginal reflex distance test 1 (MRD1) (median, 1.82; minimum, 1.0; maximum, 3.5) and change in HIT score (median, 18; minimum, 0; maximum, 30) (P = .005; r = -0.645) (Figure 2 ).
Discussion
Surgery to correct upper eyelid ptosis and dermatochalasis has been performed for both cosmetic and functional indications. Surgical indications currently in common use include impaired visual acuity, decreased peripheral vision, a compensatory chinup backward head tilt, difficulty reading, eye strain, and fatigue. 18 This study found that after ptosis repair and blepharoplasty, HIT scores are significantly better, so tension-type headache may be another indication for these surgeries.
A tension-type headache is the most common form of primary headache. Injection of botulinum toxin and excision of the corrugator superciliaris muscle are the treatment alternatives for patients with chronic, recurrent tension type-headaches. eyelids with ptosis had a vertical palpebral fissure height of zero in downgaze when the brows were relaxed. Thirty percent of their patients had subjective symptoms of an inability to read or work in the downgaze position for long periods, reported that after ptosis repair there was a significant widening of the vertical palpebral fissure height in the downgaze position. The patients also reported relief of their brow ache, fatigue, and inability to read or work in the downgaze position. In a study by Mokhtarzadeh et al, 5 patients undergoing upper eyelid surgery to repair obscuration of the superior visual field, who also reported headache symptoms for greater than 1 year, completed the HIT before and after surgery (study group). A cohort of patients undergoing other oculoplastic procedures with all type of headaches also completed the questionnaire before and after surgery (control group). Mokhtarzadeh et al 5 compared the answers to the HIT survey questions between the control and the study group preoperatively. The answers to all HIT questions on the postoperative survey were significantly better in the study group compared with the control group. They reported that correction of visually significant upper eyelid position may improve symptoms of chronic headache, similar to the results of the present study. Different from the results found by Mokhtarzadeh et al, 5 the present study selected only patients with tension-type headache. In addition, in the group undergoing ptosis repair, statistical analysis was performed specifically for the preoperative and postoperative change in MRD1 and HIT score difference. The results showed that there is a negative correlation between the changes in the MRD1 and HIT score. There was a statistically significant negative correlation between the results on the MRD1 and change in HIT score in group 2 (P = .005; r = -0.645).
with the results seen by Matsuo et al, as the preoperative HIT scores of the patients undergoing ptosis repair were higher than those of the patients undergoing blepharoplasty. In addition, the difference between the preoperative and postoperative HIT score was significantly higher in patients undergoing ptosis repair than those undergoing blepharoplasty. When only the type of ptosis repair is taken into consideration, the difference between the preoperative and postoperative HIT score was significantly higher for patients undergoing levator resection.
Limitations
This study has some limitations. First, the sample size was small for the patients undergoing ptosis repair. In this small group, statistical analysis was performed to see if the 3 types of operations were correlated with changes in the HIT score.
Second, although the HIT score depends heavily on the patients and may be considered subjective, it is an objective test and one of the major methods to evaluate headache severity and its effect on patients' daily lives; it is not possible to objectively evaluate headache severity.
Conclusions
This study has shown that repair of ptosis and upper eyelid dermatochalasis provides significant improvement in HIT scores for patients who have tension-type headache. This type of headache can be another functional indication for ptosis repair and blepharoplasty. Especially for the ptosis patients with lower results on the MRD1, correction of ptosis improves symptoms of chronic headache.
